Successful continuous nivolumab therapy for metastatic non‐small cell lung cancer after local treatment of oligometastatic lesions

The patient in this report was a 57‐year‐old man with metastatic non‐small cell lung cancer (NSCLC). After no response to two lines of systemic chemotherapy, he was treated with nivolumab as third‐line therapy, which resulted in a partial response. After 17 months of nivolumab treatment, he develope...

Descripción completa

Detalles Bibliográficos
Autores principales: Tobita, Satoshi, Kinehara, Yuhei, Tamura, Yoshio, Kurebe, Hiroyuki, Ninomiya, Ryusuke, Utsu, Yoshihiko, Kohmo, Satoshi, Sato, Bunzo, Nagai, Kenichi, Maruoka, Shintaro, Jokoji, Ryu, Koyama, Shohei, Tachibana, Isao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396382/
https://www.ncbi.nlm.nih.gov/pubmed/32567218
http://dx.doi.org/10.1111/1759-7714.13539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396382/
https://www.ncbi.nlm.nih.gov/pubmed/32567218
http://dx.doi.org/10.1111/1759-7714.13539

Ejemplares similares